George Risi

Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults

Joanne M. Langley, Louise Frenette, Linda Ferguson et al. · The Journal of Infectious Diseases · 2010 · 91 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study

Joanne M. Langley, George Risi, Michael S. Caldwell et al. · The Journal of Infectious Diseases · 2011 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

Mohamed Samai, Jane F. Seward, Susan T. Goldstein et al. · The Journal of Infectious Diseases · 2018 · 74 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age

Gustavo H. Dayan, Joan Bevilacqua, Dorothy Coleman et al. · Vaccine · 2012 · 58 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant

Murdo Ferguson, George Risi, Matthew Davis et al. · The Journal of Infectious Diseases · 2012 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17